| 1 | Agrippal S1 (Influenza vaccination) | - | - | - | - | 1件:  46 46 | 
| 2 | Belimumab plus Early Vaccination | 1件:  Belimumab Belimumab | 1件:  D03068 
                
                    D03068
                
             | 1件:  TNFSF13B TNFSF13B 💬 | 4件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件:  49 49 | 
| 3 | Belimumab plus Late Vaccination | 1件:  Belimumab Belimumab | 1件:  D03068 
                
                    D03068
                
             | 1件:  TNFSF13B TNFSF13B 💬 | 4件:  Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件:  49 49 | 
| 4 | COVID-19 vaccination | - | - | - | - | 1件:  13 13 | 
| 5 | Human papillomavirus vaccination (Gardasil) | 1件:  Human papillomavirus type 6 L1 capsid protein antigen Human papillomavirus type 6 L1 capsid protein antigen | - | - | - | 1件:  49 49 | 
| 6 | Influenza vaccination | - | - | - | - | 1件:  299 299 | 
| 7 | Measles, Mumps, Rubella vaccination | - | - | - | - | 1件:  107 107 | 
| 8 | Multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides) | - | - | - | - | 1件:  13 13 | 
| 9 | Prevenar vaccination | - | - | - | - | 1件:  46 46 | 
| 10 | T cell vaccination | - | - | - | - | 1件:  13 13 | 
| 11 | T-Cell Vaccination | - | - | - | - | 1件:  13 13 | 
| 12 | Vaccination | - | - | - | - | 1件:  49 49 | 
| 13 | Vaccination against TBE | - | - | - | - | 1件:  46 46 | 
| 14 | Vaccination with vaccine against hepatitis A and B | - | - | - | - | 1件:  299 299 |